-
Nexavar fails to meet endpoint goal in phase III study
- May 23, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Pradaxa forces patients to do their homework
- Jun 18, 2012
-
Johnson & Johnson reduces Tylenol dosage requirements
- Dec 29, 2011
-
FDA advisory panel under scrutiny for voting against Yaz recall
- Mar 27, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Fen-Phen blood thinners diet pill type 2 diabetes settlement Nexavar meningitis Gynecare Prolift prescription drugs Xarelto dabigatran hormone replacement therapy Lexapro Zimmer breast cancer regorafenib Zocor pulmonary embolism liver damage Medicaid Drugs Tempah Nexavar Bayer Actos acetaminophen Travel pulmonary embolism statin HIV test
More Dangerous Drug News
Get News Updates By Email
@ConsumerDrugRep Tweets
Archives
- June 2011 (3)
- September 2011 (1)
- October 2011 (3)
- November 2011 (5)
- December 2011 (25)
- January 2012 (8)
- February 2012 (24)
- March 2012 (20)
- April 2012 (6)
- May 2012 (12)